Related Experiment Videos
Knockout-transgenic mouse model of sickle cell disease
T M Ryan1, D J Ciavatta, T M Townes
1Department of Biochemistry and Molecular Genetics, Schools of Medicine and Dentistry, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Science (New York, N.Y.)
|November 5, 1997
Summary
Researchers developed a mouse model for sickle cell disease by creating mice that produce only human sickle hemoglobin. These mice exhibit anemia and organ damage, offering a new platform for testing therapies.
Area of Science:
- Hematology
- Genetics
- Pathology
Background:
- Sickle cell disease is a genetic blood disorder characterized by abnormal hemoglobin.
- Current research lacks adequate animal models that fully replicate human sickle cell disease pathology.
Purpose of the Study:
- To develop a novel mouse model that exclusively synthesizes human sickle hemoglobin.
- To assess the physiological and pathological consequences of human sickle hemoglobin expression in mice.
Main Methods:
- Generation of transgenic mice expressing human sickle hemoglobin.
- Cross-mating with mice possessing knockout mutations in alpha- and beta-globin genes.
- Analysis of red blood cell composition, hematological parameters, and organ pathology.
Main Results:
- Successfully produced mice synthesizing only human sickle hemoglobin in adult red blood cells.
- Developed mice exhibiting severe hemolytic anemia, extensive organ pathology, and sickled erythrocytes, mirroring human sickle cell disease.
- Observed that the majority of anemic mice survived for 2 to 9 months and remained fertile.
Conclusions:
- The developed mouse model accurately recapitulates key features of human sickle cell disease.
- This model provides a valuable platform for preclinical testing of therapeutic interventions for sickle cell disease.
- Further research can utilize this model to investigate disease mechanisms and evaluate novel drug and genetic therapies.